| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
actin related protein 1B | 0.729 | 0.231 | 1.1E-03 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
actin related protein T3 | 0.792 | 0.077 | 3.8E-08 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 1 | 1 | 1990 | 2019 | ||||||||
|
activating transcription factor 1 | 0.588 | 0.577 | 0.63 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
group | 0.100 | None | 1.000 | 6 | 2 | 2015 | 2019 | ||||||||
|
BAALC binder of MAP3K1 and KLF4 | 0.631 | 0.385 | 4.4E-03 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
BAALC antisense RNA 1 | 0.760 | 0.115 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
BRISC and BRCA1 A complex member 1 | 0.678 | 0.385 | 0.96 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BicC family RNA binding protein 1 | 0.636 | 0.577 | 0.84 |
|
group | 0.100 | None | 1.000 | 2 | 1 | 2014 | 2016 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
group | 0.410 | None | 1.000 | 2 | 1 | 2008 | 2019 | ||||||||
|
bone morphogenetic protein 5 | 0.653 | 0.577 | 9.0E-04 |
|
group | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
BOC cell adhesion associated, oncogene regulated | 0.666 | 0.423 | 1.7E-07 |
|
group | 0.410 | None | 1.000 | 1 | 1 | 2018 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
BTB domain containing 9 | 0.691 | 0.423 | 7.1E-09 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
chromosome 11 open reading frame 53 | 0.792 | 0.077 | 1.9E-03 |
|
group | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | ||||||||
|
Cdk5 and Abl enzyme substrate 2 | 0.805 | 0.077 | 2.1E-04 |
|
group | 0.100 | None | 1.000 | 3 | 1 | 2014 | 2019 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cerebellin 2 precursor | 0.751 | 0.308 | 0.12 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
group | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.420 | None | 1.000 | 4 | 3 | 2011 | 2019 | ||||||||
|
CCND2 antisense RNA 1 | 0.760 | 0.154 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | |||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.500 | None | 0.950 | 2 | 2 | 1999 | 2019 | ||||||||
|
cadherin 3 | 0.560 | 0.615 | 2.8E-10 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2008 | 2019 |